breast cancer breast cancer

Herceptin has proved to be effective in prolonging the lives of the 12 percent of women with breast cancer whose malignancy hasn't spread to other organs, and whose cancer is HER2-positive. But side effects can be a problem. Jeff J Mitchell/Getty Images hide caption

toggle caption
Jeff J Mitchell/Getty Images

Britain's Health and Social Care Secretary Jeremy Hunt arrives at 10 Downing Street in central London on March 13. Daniel Leal-Olivas/AFP/Getty Images hide caption

toggle caption
Daniel Leal-Olivas/AFP/Getty Images

Virginia Harrod, an attorney and county prosecutor who lives in rural Kentucky, survived breast cancer, only to develop lymphedema, which sent her to the hospital three times with serious infections. A lymph node transplant helped restore her immune system. Luke Sharrett for NPR hide caption

toggle caption
Luke Sharrett for NPR

She Survived Breast Cancer, But Says A Treatment Side Effect 'Almost Killed' Her

  • Download
  • <iframe src="https://www.npr.org/player/embed/585249587/587025076" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Careful custody of blood tests and tissue samples is essential to the success of precision medicine. David Silverman/Getty Images hide caption

toggle caption
David Silverman/Getty Images

Precision Medical Treatments Have A Quality Control Problem

  • Download
  • <iframe src="https://www.npr.org/player/embed/572853436/574693669" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Abu Qader, 18, came to the U.S. from Afghanistan as a baby. Now a freshman at Cornell University, he has founded a medical technology company with the goal of improving diagnosis of breast cancer in poor countries. Robert Barker/Cornell University hide caption

toggle caption
Robert Barker/Cornell University
Katherine Streeter for NPR

Even Low-Dose Contraceptives Slightly Increase Breast Cancer Risk

  • Download
  • <iframe src="https://www.npr.org/player/embed/568836583/568920367" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Kathi Kolb, a Rhode Island physical therapist, says she's frustrated that fewer than half of eligible breast cancer patients receive a shorter course of radiation, even though studies proved it was safe nearly 10 years ago. Katye Martens Brier for KHN hide caption

toggle caption
Katye Martens Brier for KHN

Lori Wallace says it's frustrating to constantly hear messages in ads for hospitals that imply her cancer would go away if she were just more positive and tried harder. Sam Harnett/KQED hide caption

toggle caption
Sam Harnett/KQED

The Painful Side Of Positive Health Care Marketing

  • Download
  • <iframe src="https://www.npr.org/player/embed/555370189/564443911" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Mammography has helped increase the early detection of breast tumors. Now, researchers say, the goal is to discern which of those tumors need aggressive treatment, including chemotherapy or radiation after surgery. Chicago Tribune/Getty Images hide caption

toggle caption
Chicago Tribune/Getty Images

Tumor Test Helps Identify Which Breast Cancers Don't Require Extra Treatment

  • Download
  • <iframe src="https://www.npr.org/player/embed/534882955/534969935" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Women have gotten conflicting advice from doctors about when to have mammograms. Amelie Benoist/Science Source hide caption

toggle caption
Amelie Benoist/Science Source

OB-GYNs Give Women More Say In When They Have Mammograms

  • Download
  • <iframe src="https://www.npr.org/player/embed/533951718/533989441" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Jill Wiseman answers questions for the Contact Center based at the Fred Hutchinson Cancer Research Center in Seattle. Robert Hood/Fred Hutch News Service hide caption

toggle caption
Robert Hood/Fred Hutch News Service

A new study suggests that some small tumors are small because they are biologically prone to slow growth. Lester Lefkowitz/Getty Images hide caption

toggle caption
Lester Lefkowitz/Getty Images

Some Small Tumors In Breasts May Not Be So Bad After All

  • Download
  • <iframe src="https://www.npr.org/player/embed/531786168/531945598" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript